Sign in
IRBS Stock Price, Chart, Stats & News
IR Biosciences Holdings Inc.
Save
IR Biosciences Holdings Inc. (IRBS) does not currently pay a dividend.
128,122
Market cap
–
Current P/E
–
Forward P/E
IRBS chart
Price history is unavailable
We don't have enough price data for IRBS to draw a chart yet.
About
Health care
Sector
Biotechnology
Industry
IR BioSciences Holdings, Inc. is a U. S.-based, early-stage biotechnology firm. Through its subsidiary, ImmuneRegen BioSciences, Inc., it concentrates on researching and developing therapies for significant health challenges, including pulmonary fibrosis, influenza infections, and neutropenia caused by radiation.
Similar securities
Based on sector and market capitalization
Report issue